Current Questions
Considering the information presented above, the following are meant to be discussion points:
  1. Because TV annulus dilation as predictor of TR progression and criteria to indicate concomitant surgery is, still nowadays, controversial, is there a significant benefit of unrestricted prophylactic TV intervention? Or a watch-and-wait strategy with subsequent intervention, if necessary, could be a valuable alternative in some subgroup of patients? What patients’ profile could benefit from a more conservative strategy?
  2. Once one of the reasons to indicate concomitant TV repair is the assumption that a future reoperation would be associated with high surgical risk and poor outcomes, in a hypothetical scenario of TTVI providing significant lower procedural mortality, should this argument be reviewed?
  3. If the indication of tricuspid prophylactic intervention based on annulus dilation is valid, should also TTVI be indicated in symptomatic, high-risk patients, based in annular dilation (≥ 40mm) rather than TR grade?